| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Granulysin Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 15 - 16 kDa, reducing conditions. MW (theoretical): 15.4 kDa. The Recombinant Human Granulysin Protein from R&D Systems is derived from NS0. The Recombinant Human Granulysin Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 25 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | D2S69Elymphocyte-activation gene 2, GNLY, granulysin, LAG2, LAG-2, Lymphokine, Lymphokine LAG-2, NKG5, NKG5519, Protein NKG5, TLA519, TLA519T-cell activation protein 519, T-lymphocyte activation gene 519 |
|---|
| Gene, Accession, CAS # | GNLY, Gene ID: 10578, Accession: P22749 |
|---|
| Catalog # | 3138-GN-025/CF |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Granulysin Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 20660289, 22723518, 27276051 |
|---|
| 产品资料 |
|
|